Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
6.32M
-
Shares change
-
-799K
-
Total reported value, excl. options
-
$285M
-
Value change
-
-$31.1M
-
Put/Call ratio
-
0.83
-
Number of buys
-
61
-
Number of sells
-
-57
-
Price
-
$45.12
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2015
145 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q4 2015.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.32M shares
of 22.3M outstanding shares and own 28.37% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (946K shares), BlackRock Fund Advisors (635K shares), SENZAR ASSET MANAGEMENT, LLC (454K shares), STATE STREET CORP (388K shares), VANGUARD GROUP INC (361K shares), Healthcare Value Capital, LLC (320K shares), DEUTSCHE BANK AG\ (219K shares), BlackRock Institutional Trust Company, N.A. (191K shares), Allianz Asset Management AG (183K shares), and NOMURA HOLDINGS INC (167K shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.